TO THE EDITOR
I am a bachelor-degreed pharmacist who does not believe that everyone filling a prescription needs a PharmD.1 In my experience, expanding PharmD programs has reduced the supply of pharmacists in a market that is experiencing a staggering demand for practitioners. This is a prescription for higher costs through higher wage demands.
When the University of Colorado School of Pharmacy switched to a PharmD program, it decreased its available enrollment from 120 students to 90. The Colorado legislature had given the university no budget increase. To spend the same amount to educate students for 4 years as it did for 3, the school was forced to reduce enrollment by 25%. In the not too distant past, insurance companies allowed up to 100 tablets to be dispensed on one prescription. When they switched to authorizing a 30-day supply, this meant many more prescriptions were dispensed. Many 100-tablet prescriptions that could have been dispensed in their original container now had to be counted with 30 tablets being dispensed.
This has lengthened the time to fill a prescription, yet customers are less patient to wait. So the retail pharmacy chains in the US are building many more stores. For example, in 2000, Walgreen’s opened a store on the average of 1 every 19 hours, and it will continue to do so throughout 2001. Yet there are only so many pharmacists in the pool. To get them Walgreen’s is paying huge salaries. A colleague recently accepted a position at Walgreen’s at a $19.00 per hour raise! Walgreen’s has been quoted as saying it would be happy if it could hire every pharmacy graduate in the 2001 class. Think of that!—none for anyone else.
If you were offered a $19.00 an hour pay raise would you accept? There are only a few of us who are willing to stay in hospitals, and we are being very tempted. There will probably be another class of pharmacists soon.
Al Lodwick, RPh, MA
St. Mary-Corwin Medical Center
Pueblo, CO
1. Montoya ID. Is the healthcare workforce a barrier to cost containment? Am J Manag Care 2000;6:971-972.
Insurance Payer Is Associated With Length of Stay After Traumatic Brain Injury
February 21st 2025Among hospitalized patients with traumatic brain injury, Medicaid fee-for-service was associated with longer hospital stays than private insurance and Medicaid managed care organizations.
Read More
Managed Care Reflections: Insights From Richard J. Gilfillan, MD; and Donald M. Berwick, MD, MPP
February 20th 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes reflections from a thought leader on what has changed over the past 3 decades and what’s next for managed care. The February issue features a retrospective by Richard J. Gilfillan, MD, former director of the Center for Medicare and Medicaid Innovation; and Donald M. Berwick, MD, MPP, former administrator of CMS.
Read More
Medical Policy Determinations for Pharmacogenetic Tests Among US Health Plans
February 10th 2025This analysis demonstrated significant variability in medical policy determinations and evidence cited for clinically relevant pharmacogenetic tests among major US health insurers and laboratory benefit managers.
Read More